Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoichi Fukui

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Internal Medicine (Tokyo, Japan)|March 13, 2018
Rituximab-induced Acute Thrombocytopenia in Granulomatosis with PolyangiitisYushiro Endo, Tomohiro Koga, Midori Ishida, et al.
Frontiers in Immunology|June 14, 2021
NLRP3 Inflammasome Assembly in Neutrophils Is Supported by PAD4 and Promotes NETosis Under Sterile ConditionsPatrick Münzer, Roberto Negro, Shoichi Fukui, et al.
Internal Medicine (Tokyo, Japan)|November 19, 2019
Drop Head Syndrome as a Rare Complication in Mixed Connective Tissue DiseaseMidori Akagi, Masataka Umeda, Mikiko Hashisako, et al.
Frontiers in Immunology|January 30, 2018
M1 and M2 Monocytes in Rheumatoid Arthritis: A Contribution of Imbalance of M1/M2 Monocytes to OsteoclastogenesisShoichi Fukui, Naoki Iwamoto, Ayuko Takatani, et al.
Modern Rheumatology|May 17, 2024
Successful treatment of systemic lupus erythematosus with residual disease activity by switching from belimumab to anifrolumabMasataka Umeda, Kanako Kojima, Toru Michitsuji, et al.
Arthritis Research & Therapy|December 15, 2016
Fewer subsequent relapses and lower levels of IL-17 in Takayasu arteritis developed after the age of 40 yearsShoichi Fukui, Naoki Iwamoto, Toshimasa Shimizu, et al.
Internal Medicine (Tokyo, Japan)|May 22, 2018
Reversible Cognitive Dysfunction in Elderly-onset Systemic Lupus Erythematosus, Successfully Treated with Aggressive Immunosuppressive TherapyYuya Fujita, Shoichi Fukui, Midori Ishida, et al.
Internal Medicine (Tokyo, Japan)|August 28, 2018
Scleroderma Renal Crisis Complicated with Thrombotic Microangiopathy Triggered by Influenza B Virus InfectionToshimasa Shimizu, Naoki Iwamoto, Momoko Okamoto, et al.
Clinical Immunology (Orlando, Fla.)|October 9, 2018
Podocyte foot process width is a prediction marker for complete renal response at 6 and 12 months after induction therapy in lupus nephritisKunihiro Ichinose, Mineaki Kitamura, Shuntaro Sato, et al.
Plos One|May 5, 2017
Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritisNaoki Iwamoto, Sosuke Tsuji, Ayuko Takatani, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Internal Medicine (Tokyo, Japan)|March 13, 2018
Rituximab-induced Acute Thrombocytopenia in Granulomatosis with PolyangiitisYushiro Endo, Tomohiro Koga, Midori Ishida, et al.
Frontiers in Immunology|June 14, 2021
NLRP3 Inflammasome Assembly in Neutrophils Is Supported by PAD4 and Promotes NETosis Under Sterile ConditionsPatrick Münzer, Roberto Negro, Shoichi Fukui, et al.
Internal Medicine (Tokyo, Japan)|November 19, 2019
Drop Head Syndrome as a Rare Complication in Mixed Connective Tissue DiseaseMidori Akagi, Masataka Umeda, Mikiko Hashisako, et al.
Frontiers in Immunology|January 30, 2018
M1 and M2 Monocytes in Rheumatoid Arthritis: A Contribution of Imbalance of M1/M2 Monocytes to OsteoclastogenesisShoichi Fukui, Naoki Iwamoto, Ayuko Takatani, et al.
Modern Rheumatology|May 17, 2024
Successful treatment of systemic lupus erythematosus with residual disease activity by switching from belimumab to anifrolumabMasataka Umeda, Kanako Kojima, Toru Michitsuji, et al.
Arthritis Research & Therapy|December 15, 2016
Fewer subsequent relapses and lower levels of IL-17 in Takayasu arteritis developed after the age of 40 yearsShoichi Fukui, Naoki Iwamoto, Toshimasa Shimizu, et al.
Internal Medicine (Tokyo, Japan)|May 22, 2018
Reversible Cognitive Dysfunction in Elderly-onset Systemic Lupus Erythematosus, Successfully Treated with Aggressive Immunosuppressive TherapyYuya Fujita, Shoichi Fukui, Midori Ishida, et al.
Internal Medicine (Tokyo, Japan)|August 28, 2018
Scleroderma Renal Crisis Complicated with Thrombotic Microangiopathy Triggered by Influenza B Virus InfectionToshimasa Shimizu, Naoki Iwamoto, Momoko Okamoto, et al.
Clinical Immunology (Orlando, Fla.)|October 9, 2018
Podocyte foot process width is a prediction marker for complete renal response at 6 and 12 months after induction therapy in lupus nephritisKunihiro Ichinose, Mineaki Kitamura, Shuntaro Sato, et al.
Plos One|May 5, 2017
Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritisNaoki Iwamoto, Sosuke Tsuji, Ayuko Takatani, et al.
Pageof 13